Glial vascular degeneration in CADASIL

Journal of Alzheimer's Disease

Volumn 21, Issue 4, 2010, Pages 1393-1402

  Brennan Krohn, Thea ^a   Salloway, Stephen ^a   Correia, Stephen ^a   Dong, Matthew ^a   De La Monte, Suzanne M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Aspartyl (asparaginyl) hydroxylase; human; Notch; vascular dementia; white matter degeneration

Indexed keywords

ASPARTYLASPARAGINYL BETA HYDROXYLASE; ENDOTHELIN 1; GLIAL FIBRILLARY ACIDIC PROTEIN; INSULIN; MESSENGER RNA; MYELIN ASSOCIATED GLYCOPROTEIN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; OXYGENASE; SMOOTH MUSCLE ACTIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN DAMAGE; CADASIL; CASE REPORT; CELL LOSS; CONTROLLED STUDY; GENE EXPRESSION; GLIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MENINX; NERVE CELL; NERVE DEGENERATION; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WHITE MATTER;

EID: 78650457398     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100036     Document Type: Article

References (52)

1. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lath-rop GM, Chabriat H, Mas JL, Cabanis EA, Baudrimont M, Maciazek J, et al. (1993) Cerebral autosomal dominant ar-teriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3, 256-259.
2. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mou-ton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707710.
3. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X et al. (1995) Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 346, 934-939.
4. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44, 731-739.
5. Salloway S, Brennan-Krohn T, S C, Mellion M, de la Monte S (2009) CADASIL: A genetic model of arteriolar degeneration, white matter injury, and dementia in later life. In Behavioral Neurology of Dementia, Miller B, Boeve B, eds, Cambridge University, New York, pp. 329-344.
6. Salloway S, Desbiens S (2004) CADASIL and Other Genetic Causes of Stroke and Vascular Dementia In Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management, Paul R, Cohen R, Ott B, Salloway S, eds. Humana Press, Totowa, NJ, pp. 87-98.
7. Yamamoto Y, Ihara M, Tham C, Low RW, Slade JY, Moss T, Oakley AE, Polvikoski T, Kalaria RN (2009) Neuropatholog-ical correlates of temporal pole white matter hyperintensities in CADASIL. Stroke 40, 2004-2011.
8. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powell JF (2002) Diagnostic strategies in CADASIL. Neurology 59, 1134-1138.
9. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 105, 597-605.
10. Donahue CP, Kosik KS (2004) Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL. Genomics 83, 59-65.
11. Bray SJ (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7, 678-689.
12. Ehebauer M, Hayward P, Arias AM (2006) Notch, a universal arbiter of cell fate decisions. Science 314, 1414-1415.
13. Lopez SL, Paganelli AR, Siri MV, Ocana OH, Franco PG, Carrasco AE (2003) Notch activates sonic hedgehog and both are involved in the specification of dorsal midline cell-fates in Xenopus. Development 130, 2225-2238.
14. Lutolf S, Radtke F, Aguet M, Suter U, Taylor V (2002) Notch1 is required for neuronal and glial differentiation in the cerebellum. Development 129, 373-385.
15. Patten BA, Peyrin JM, Weinmaster G, Corfas G (2003) Sequential signaling through Notch1 and erbB receptors mediates radial glia differentiation. J Neurosci 23, 6132-6140.
16. Solecki DJ, Liu XL, Tomoda T, Fang Y, Hatten ME (2001) Activated Notch2 signaling inhibits differentiation of cerebel-lar granule neuron precursors by maintaining proliferation. Neuron 31, 557-568.
17. Weinmaster G (1997) The ins and outs of notch signaling. Mol Cell Neurosci 9, 91-102.
18. Bianchi S, Dotti MT, Federico A (2006) Physiology and pathology of notch signalling system. J Cell Physiol 207, 300308.
19. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN (2002) CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12, 371-384.
20. Dinchuk JE, Focht RJ, Kelley JA, Henderson NL, Zolotar-jova NI, Wynn R, Neff NT, Link J, Huber RM, Burn TC, Rupar MJ, Cunningham MR, Selling BH, Ma J, Stern AA, Hollis GF, Stein RB, Friedman PA (2002) Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasia. J Biol Chem 277, 12970-12977.
21. Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, Wands JR (2006) Aspartyl-asparagyl beta hy-droxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology 44, 446-457.
22. Lahousse SA, Carter JJ, Xu XJ, Wands JR, de la Monte SM (2006) Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC Cell Biol 7, 41.
23. Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, Wands JR, Friedman PA (1996) Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest 98, 1313-1323.
24. Dinchuk JE, Henderson NL, Burn TC, Huber R, Ho SP, Link J, O'Neil KT, Focht RJ, Scully MS, Hollis JM, Hollis GF, Friedman PA (2000) Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform ofAsph missing the catalytic domain share exons with junctin. J Biol Chem 275, 3954339554.
25. Monkovic DD, VanDusen WJ, Petroski CJ, Garsky VM, Sar-dana MK, Zavodszky P, Stern AM, Friedman PA (1992) Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modules. Biochem Biophys Res Commun 189, 233-241.
26. Kopan R, Schroeter EH, Weintraub H, Nye JS (1996) Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci USA 93, 1683-1688.
27. Schroeter EH, Kisslinger JA, Kopan R (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracel-lular domain. Nature 393, 382-386.
28. de La Coste A, FreitasAA (2006) Notch signaling: distinct lig-ands induce specific signals during lymphocyte development and maturation. Immunol Lett 102, 1-9.
29. Carter JJ, Tong M, Silbermann E, Lahousse SA, Ding FF, Longato L, Roper N, Wands JR, de la Monte SM (2008) Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression. Acta Neuropathol 116, 303-315.
30. de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wied-mann M, Carter JJ, Lahousse SA, Califano S, Maeda T, Ueno T, D'Errico A, Trevisani F, Wands JR (2006) Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. J Hepatol 44, 971-983.
31. de la Monte SM, Tong M, Carlson RI, Carter JJ, Longato L, Silbermann E, Wands JR (2009) Ethanol inhibition ofaspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration. Alcohol 43, 225-240.
32. Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, Wands JR, de la Monte SM (2002) Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility. Lab Invest 82, 881-891.
33. Dudek SM, Garcia JG (2001) Cytoskeletal regulation of pulmonary vascular permeability. JAppl Physiol 91, 1487-1500.
34. Li S, Moon JJ, Miao H, Jin G, Chen BP, Yuan S, Hu Y, Usami S, Chien S (2003) Signal transduction in matrix contraction and the migration of vascular smooth muscle cells in three-dimensional matrix. J VascRes 40, 378-388.
35. Tang DD, Anfinogenova Y (2008) Physiologic properties and regulation ofthe actin cytoskeleton in vascular smooth muscle. J Cardiovasc Pharmacol Ther 13, 130-140.
36. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8, 247-268.
37. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease -is this type 3 diabetes? J Alzheimers Dis 7, 63-80. (Pubitemid 40387185)
38. Lahousse SA, Stopa EG, Mulberg AE, de la Monte SM (2003) Reduced expression of the cystic fibrosis transmembrane conductance regulator gene in the hypothalamus of patients with Alzheimer's disease. J Alzheimers Dis 5, 455-462.
39. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, Krause DN (2002) Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33, 1685-1691.
40. Costello P, Del Maestro R (1990) Human cerebral endothelium: isolation and characterization of cells derived from mi-crovessels of non-neoplastic and malignant glial tissue. J Neu-rooncol 8, 231-243.
41. Tsuji T, Mimori Y, Nakamura S, Kameyama M (1987) A micromethod for the isolation of large and small microvessels from frozen autopsied human brain, J Neurochem 49, 17961800.
42. de la Monte SM, Tong M, Cohen AC, Sheedy D, Harper C, Wands JR (2008) Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration. Alcohol Clin ExpRes, 32: 1630-1644.
43. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9, 13-33.
44. Peters N, Holtmannspotter M, Opherk C, Gschwendtner A, Herzog J, Samann P, Dichgans M (2006) Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology 66, 1517-1522.
45. Tatsch K, Koch W, Linke R, Poepperl G, Peters N, Holtmannspoetter M, Dichgans M (2003) Cortical hy-pometabolism and crossed cerebellar diaschisis suggest sub-cortically induced disconnection in CADASIL: an 18F-FDG PET study. JNuclMed 44, 862-869.
46. Treves S, Feriotto G, Moccagatta L, Gambari R, Zorzato F (2000) Molecular cloning, expression, functional characterization, chromosomal localization, and gene structure of junctate, a novel integral calcium binding protein of sar-co(endo)plasmic reticulum membrane. J Biol Chem 275, 39555-39568.
47. Chesik D, De Keyser J, Wilczak N (2008) Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J Mol Neurosci 35, 81-90.
48. Joseph D'Ercole A, Ye P (2008) Expanding the mind: insulinlike growth factor I and brain development. Endocrinology 149, 5958-5962.
49. Ishiko A, Shimizu A, Nagata E, Takahashi K, Tabira T, Suzuki N (2006) Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol 112, 333-339.
50. Goldbaum O, Richter-Landsberg C (2004) Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment ofubiquitin to tau-positive aggregates in oligo-dendrocytes in culture. J Neurosci 24, 5748-5757.
51. Olanow CW (2007) The pathogenesis of cell death in Parkinson's disease -2007. Mov Disord 22(Suppl 17), S335-342.
52. Uchiyama Y, Koike M, Shibata M (2008) Autophagic neuron death in neonatal brain ischemia/hypoxia. Autophagy 4, 404408.